Boston Scientific Corp (XTER:BSX)
€ 87 1.5 (1.75%) Market Cap: 126.63 Bil Enterprise Value: 134.92 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 79/100

Boston Scientific Corp at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 01:00PM GMT
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Okay. Thanks, everyone, for joining us this morning. It's a real pleasure. We have Boston Scientific to kick off our Annual Healthcare Conference. It is a relief that this is the last health care conference. No more conferences until the holiday season. So we know representing the company, we have the CEO and Chairman, Mike Mahoney. And from IR, we have Susie Lisa and Lauren Tengler. Real pleasure to have all of you this morning.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Mike, maybe I'll start with a big-picture question. I saw the divestiture this morning, so congrats on the transaction. Before we get there, this has been an unusual year for Boston. Stock's been choppy. We've had some 2 steps forward, 1 step backward, if you will. A question that I've been getting is has anything changed at Boston? If you look at the stock, this has been such a home run over the last 5 years. Has something changed for Boston?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot